US2009023601A1PendingUtilityA1
Gel having biosubstance fixed thereto and microarray utilizing the gel
Est. expiryApr 3, 2022(expired)· nominal 20-yr term from priority
B01J 2219/0052B01J 2219/00673B01J 2219/00639B01J 2219/00585B01J 19/0046B01J 2219/00641B01J 2219/00524B01J 2219/00722B01J 2219/00576C12M 1/00B01J 2219/00596Y10T428/1352B01J 2219/00659B01J 2219/00644G01N 37/00G01N 33/53B01J 2219/00317
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides a biological substance-immobilized gel which comprises a gel containing 2%-7% by mass of N,N-dimethylacrylamide and a biological substance immobilized on and/or in the gel.
Claims
exact text as granted — not AI-modified1 - 7 . (canceled)
8 . A gel-filled hollow tube which comprises a hollow tube whose hollow space is filled with the biological substance-immobilized gel which comprises a gel containing 2%-7% by mass of N,N-dimethylacrylamide and a biological substance immobilized on and/or in the gel.
9 . The gel-filled hollow tube according to claim 8 , wherein the hollow tube is a hollow fiber.
10 . A method for manufacturing a biological substance-immobilized gel microarray, which comprises allowing a plurality of gel-filled hollow tubes according to claim 8 to be tied in a bundle and cutting the resulting tube bundle in a direction intersecting with the longitudinal direction of the tubes.
11 . A method for manufacturing a biological substance-immobilized gel microarray, which comprises the following steps:
(1) allowing a plurality of hollow tubes to be tied in a bundle; (2) filling the biological substance-immobilized gel which comprises a gel containing 2%-7% by mass of N,N-dimethylacrylamide and a biological substance immobilized on and/or in the gel. into the hollow space of each tube in the resulting tube bundle; and (3) cutting the tube bundle in a direction intersecting with the longitudinal direction of the tubes.
12 . A biological substance-immobilized gel microarray which comprises the biological substance-immobilized gel which comprises a gel containing 2%-7% by mass of N,N-dimethylacrylamide and a biological substance immobilized on and/or in the gel, wherein the gel is arranged in multiple compartments.
13 . The biological substance-immobilized gel microarray according to claim 12 , wherein the surface area of each compartment is 10 −6 m 2 or less.
14 . The biological substance-immobilized gel microarray according to claim 12 , wherein the compartments are formed by slots or through holes.
15 . A biological substance-immobilized gel microarray which is obtained by allowing a plurality of gel-filled hollow tubes according to claim 8 to be tied in a bundle and cutting the tube bundle in a direction intersecting with the longitudinal direction of the tubes.
16 . The biological substance-immobilized gel microarray according to claim 15 , wherein the hollow tubes are hollow fibers.
17 - 19 . (canceled)
20 . The gel-filled hollow tube according to claim 8 , which comprises a gel having the following composition and a biological substance immobilized on and/or in the gel:
(a) N,N-dimethylacrylamide
2% to 7%
by mass
(b) cross-linking agent
0.1% to 1.5%
by mass.
21 . The gel-filled hollow tube according to claim 8 , wherein the biological substance is a nucleic acid.
22 . The gel-filled hollow tube according to claim 20 , wherein the cross-linking agent is a multifunctional monomer having at least two ethylenically unsaturated bonds.
23 . The biological substance-immobilized gel according to claim 22 , wherein the cross-linking agent is methylenebisacrylamide.Join the waitlist — get patent alerts
Track US2009023601A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.